still hungry on retatrutide Reta? Understanding Persistent Appetite There's so much talk about

In a public advisory on Wednesday, Health Canada said that as interest grows in GLP-1 products for weight loss, "some people may turn to unauthorized or counterfeit products, which could pose serious health risks because they have not been assessed by Health Canada for safety, effectiveness, or quality." The versions of the medications authorized for use in Canada are semaglutide (Ozempic and Wegovy injections and Rybelsus oral tablets) and tirzepatide (Mounjaro and Zepbound injections)

A recent retrospective cohort study looked at GLP-1 adherence in patients with obesity and with/without diabetes: Those with T2DM: 46.5% discontinued by year one 64.1% discontinued by year two Those without T2DM: 64.8% discontinued by year one 84.4% discontinued by year two So yes access is a problem

Participants experienced significant reductions in blood pressure, lipid profiles (except HDL cholesterol), and waist circumference, all of which are important markers of cardiometabolic health

The air swallowing factor There is another contributor that most guides overlook